Aspen to release first batch of Johnson & Johnson Covid-19 vaccines

accreditation
0:00
play article
Subscribers can listen to this article
Stephen Saad, CEO of Aspen Pharmacare
Stephen Saad, CEO of Aspen Pharmacare
Lulama Zenzile

South Africa’s largest pharmaceutical company Aspen Pharmacare will release the first batch of the Johnson & Johnson Covid-19 vaccines on Monday. 

The local manufacturer of the vaccines said they will be released from its Gqeberha manufacturing site in the Eastern Cape and will be made available through the African Union’s African Vaccination Acquisition Task Team platform.

Aspen is manufacturing 220 million doses of the Johns & Johnson vaccine for African countries, at the more than R3 billion sterile manufacturing facility. South Africa has placed an initial order for 30 million doses. Earlier this year President Cyril Ramaphosa said the doses will later be increased to 400 million. And the US has pledged $200 million to support Aspen. 

The group's Gqeberha facility is Africa’s only manufacturing site that has been contracted by a global pharmaceutical company for large scale production of the vaccines. Aspen said the vaccines, which are the first to be produced on the continent, will also be made available to Europe and other overseas countries. 

"Aspen is proud of the role we are playing in producing vaccines for distribution in South Africa, across Africa and the world. Our ability to produce these vaccines on behalf of Johnson & Johnson builds on our strategic vision of delivering high quality, affordable medicines that improve health outcomes for patients in our own country, continent and around the world," Aspen group CEO Stephen Saad said. 

Covid-19 vaccine access inequality has been a point of concern and Saad added that supplying to Africa and the local market is "particularly rewarding".

Earlier in June Aspen had to dispose of two million vaccines it manufactured at the Gqeberha plant due to suspicions that a core component of the vaccine was contaminated in a US factory.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
17.41
-1.2%
Rand - Pound
21.50
-0.6%
Rand - Euro
18.89
-0.9%
Rand - Aus dollar
12.29
-0.4%
Rand - Yen
0.13
-0.5%
Platinum
1,009.02
-0.4%
Palladium
1,637.70
-0.5%
Gold
1,922.40
-0.3%
Silver
23.59
-0.1%
Brent Crude
86.66
-0.9%
Top 40
74,344
-0.6%
All Share
80,325
-0.6%
Resource 10
77,934
+0.1%
Industrial 25
102,701
-1.1%
Financial 15
16,323
+0.3%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders